Document Detail


Glucocorticoids upregulate high-affinity, high-density lipoprotein binding sites in rat hepatocytes.
MedLine Citation:
PMID:  7783657     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Glucocorticoid hormones (GL) regulate high-density lipoprotein (HDL) plasma concentrations by increasing synthesis and secretion of HDL by the liver. However, little is known about the effect of GL on the uptake and processing of HDL by hepatocytes (HEP). To investigate this question, we studied the effects of dexamethasone (DEX) on the expression of high-affinity HDL-binding sites via the specific binding and internalization of iodine-labeled apolipoprotein E (apo E)-free HDL3 in a culture of rat HEP. Specific binding and internalization of HDL3 decreased by 60% in cells cultured in the absence of DEX for 48 hours. At concentrations of 10(-7) and 10(-5) mol/L, DEX prevented the decrease, maintaining specific binding and internalization versus the control level (at 24 hours). HDL-binding sites with a Kd of 20 micrograms/mL were revealed on the surface of cultured HEP. HEP demonstrated a greater binding capacity in the presence of DEX at concentrations of 10(-7) and 10(-5) mol/L (125 v 45 ng/mg cell protein). The effect of the hormone has demonstrated to be dose-dependent at concentrations between 10(-9) and 10(-7) mol/L, leveling off at 10(-7). Higher concentrations did not induce a further increase in specific binding and internalization. Withdrawal of the hormone from culture medium was associated with a decrease in specific binding of the ligand by 60% in the following 24 hours. To investigate the effect of glucocorticoid deficiency on liver uptake of HDL in vivo, specific binding and internalization were studied in a culture of HEP isolated from adrenalectomized rats (AER) at 2 hours after seeding.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
A V Bocharov; W Huang; T G Vishniakova; E V Zaitseva; E G Frolova; P Rampal; R Bertolotti
Related Documents :
8624107 - Differential regulation of app secretion by apolipoprotein e3 and e4.
7937987 - A single-base substitution in the proximal sp1 site of the human low density lipoprotei...
165177 - Hydrophobic interactions of the apo-gln-i polypeptide component of human high density s...
3676267 - Physical-chemical interaction of heparin and human plasma low-density lipoproteins.
1390717 - Quantitative footprinting analysis of the chromomycin a3--dna interaction.
23742937 - Recognition of intermolecular g-quadruplexes by full length nucleophosmin. effect of a ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Metabolism: clinical and experimental     Volume:  44     ISSN:  0026-0495     ISO Abbreviation:  Metab. Clin. Exp.     Publication Date:  1995 Jun 
Date Detail:
Created Date:  1995-07-14     Completed Date:  1995-07-14     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375267     Medline TA:  Metabolism     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  730-8     Citation Subset:  IM    
Affiliation:
Cardiology Research Center, Moscow, Russia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenalectomy
Animals
Binding Sites / drug effects
Cells, Cultured
Cholesterol / biosynthesis
Cycloheximide / pharmacology
Dexamethasone / pharmacology*
Humans
Lipoproteins, HDL / metabolism*
Liver / cytology,  metabolism*
Lovastatin / pharmacology
Male
Rats
Rats, Wistar
Chemical
Reg. No./Substance:
0/Lipoproteins, HDL; 50-02-2/Dexamethasone; 57-88-5/Cholesterol; 66-81-9/Cycloheximide; 75330-75-5/Lovastatin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of short-term treatment with recombinant human growth hormone on lipids and lipoproteins in w...
Next Document:  Effect of combined administration of growth hormone (GH)-releasing hormone, GH-releasing peptide-6, ...